NCT03410342

Brief Summary

The CIRCUS study is a randomised controlled, cross-over trial to evaluate the effects of increased intakes of citrus fruits and cruciferous vegetables on vascular function in 36 untreated, prehypertensive participants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 4, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 25, 2018

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 21, 2021

Completed
Last Updated

March 22, 2022

Status Verified

March 1, 2022

Enrollment Period

3.8 years

First QC Date

December 3, 2017

Last Update Submit

March 7, 2022

Conditions

Keywords

Blood PressureVascular StiffnessCardiovascular Risk FactorFruit and vegetable

Outcome Measures

Primary Outcomes (1)

  • Blood pressure

    Changes in systolic and diastolic blood pressure (mmHg) measured by automated oscillometric device (average of 3 measurements).

    Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks

Secondary Outcomes (10)

  • Arterial stiffness

    Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks

  • Markers of cardiometabolic health measured in fasted blood samples

    Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks

  • Markers of endothelial function measured in fasted blood samples

    Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks

  • Markers of low-grade inflammation measured in fasted blood samples

    Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks

  • Urinary metabolic profiles

    Measured on the morning after each of three recurring run-in periods and after each of three recurring 2-week intervention periods, 6 times total during 9 weeks

  • +5 more secondary outcomes

Study Arms (3)

Low Fruits and Vegetables (LFV)

PLACEBO COMPARATOR

1 portion of fruits plus 1 portion of vegetables, of commonly consumed types per day. Intakes are at 25th percentile of UK consumption (NDNS) and will exclude citrus fruits, cruciferous and allium vegetables.

Other: LFV

High Fruits and Vegetables (HFV)

EXPERIMENTAL

4 portions of fruits plus 4 portions of vegetables, of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.

Other: HFV

High Citrus fruits and Cruciferous vegetables (CC)

EXPERIMENTAL

4 portions of citrus fruits plus 4 portions of cruciferous vegetables per day excluding any other types of fruits and vegetables including allium vegetables.

Other: CC

Interventions

LFVOTHER

1 apple/banana/small bunch of grapes per day plus 1 portion of carrot/pepper/tomato per day

Low Fruits and Vegetables (LFV)
HFVOTHER

4 portions of fruits (apples, bananas, grapes, pears) plus 4 portions of vegetables (carrots, cucumber, sweet peppers, tomatoes), of commonly consumed types per day excluding citrus fruits, cruciferous and allium vegetables.

High Fruits and Vegetables (HFV)
CCOTHER

4 portions of citrus fruits (clementines, grapefruits, lemons, oranges) plus 4 portions of cruciferous vegetables (broccoli, brussels sprouts, cauliflower, kale, savoy cabbage) per day.

High Citrus fruits and Cruciferous vegetables (CC)

Eligibility Criteria

Age40 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years
  • Average systolic blood pressure of 125-140 mmHg at 2 measurements separated by \>30 minutes
  • No use of antihypertensive medication
  • No reported current or previous diabetes mellitus, (secondary) hypertension, or metabolic, cardiovascular, renal, liver, thyroid, gastrointestinal diseases
  • Body Mass Index between 20 - 35 kg/m2
  • Non-smoker
  • Average fruit and vegetable consumption of \<4 portions per day (UK average, 40-65 years), or willing to reduce habitual daily fruit and vegetable intake.

You may not qualify if:

  • Any medication likely to interfere with energy metabolism, appetite regulation and hormonal balance.
  • Excessive alcohol intake of \> 21 units per week (females) or \>28 units per week (male) and not willing to limit alcohol intake to maximum of 1 unit/day
  • Physical activity of \>=10 hours/week of moderate to vigorous physical activity
  • Weight loss or gain of \>=3 kg in the preceding 3 months
  • Use of dietary supplements or unwilling to stop supplement use \>= 2 weeks before enrolment and during intervention
  • Pregnancy or lactation
  • Intervention specific factors, including:
  • Unable or unwilling to consume provided diets during the intervention
  • Unsufficient storage space for provided diets
  • Food sensitivities or vegetarian/vegan diet by choice
  • Participation in another intervention study at the same time
  • Living \> 15 miles from the Imperial/NIHR Clinical Research Facility at Hammersmith Hospital
  • No signed informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Cambridge Epidemiology & Trials Unit

Cambridge, United Kingdom

Location

Imperial/NIHR Clinical Research Facility

London, W12 0HS, United Kingdom

Location

Study Officials

  • Linda Oude Griep, PhD

    MRC Epidemiology Unit, University of Cambridge

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Associate

Study Record Dates

First Submitted

December 3, 2017

First Posted

January 25, 2018

Study Start

September 4, 2017

Primary Completion

June 21, 2021

Study Completion

June 21, 2021

Last Updated

March 22, 2022

Record last verified: 2022-03

Data Sharing

IPD Sharing
Will share

As describe in study protocol

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
In a timely manner when results have been published in peer-reviewed journals.

Locations